ATAI (AtaiBeckley) Institutional Ownership: 27.13% (As of Jul. 25, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ATAI AtaiBeckley Inc ATAI
55 GF Score
Price $7.18
GF Value $6.68
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is AtaiBeckley Institutional Ownership?

AtaiBeckley ATAI 55 Institutional Ownership is 27.13% as of Jul. 25, 2026. GuruFocus rates ATAI with a GF Score™ of 55/100 and a GF Value™ of $6.68 (Fairly Valued). The stock has 6 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, AtaiBeckley's institutional ownership is 27.13%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, AtaiBeckley's Insider Ownership is 2.36%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, AtaiBeckley's Float Percentage Of Total Shares Outstanding is 84.77%.

AtaiBeckley Institutional Ownership Historical Data

* Premium members only.

The historical data trend for AtaiBeckley's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AtaiBeckley Institutional Ownership Chart

AtaiBeckley Historical Data

The historical data trend for AtaiBeckley can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 5.16 5.71 4.45 5.10 4.87 5.20 11.64 12.09 12.13 21.28
ATAI
55GF Score
AtaiBeckley Inc ATAI
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AtaiBeckley Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 27.13% mean?
AtaiBeckley (ATAI) has a Institutional Ownership of 27.13% as of Jul. 25, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on AtaiBeckley and its competitors.
Is AtaiBeckley's Institutional Ownership too high?
AtaiBeckley's current Institutional Ownership is 27.13%. Overall, AtaiBeckley has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does AtaiBeckley's Institutional Ownership compare to GHRS and NUVB?
AtaiBeckley's Institutional Ownership of 27.13% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on AtaiBeckley and its competitors. AtaiBeckley's current Institutional Ownership is 27.13%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AtaiBeckley stock overvalued right now?
Based on GuruFocus' analysis, AtaiBeckley (ATAI) is currently considered Fairly Valued. The stock's GF Value™ is $6.68, compared to a current price of $7.18 — trading 7.4% above its estimated fair value. The current Institutional Ownership is 27.13%. AtaiBeckley's overall GF Score™ is 55/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For AtaiBeckley (ATAI), the current Institutional Ownership is 27.13% as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AtaiBeckley (ATAI) Overvalued in 2026?

Based on GuruFocus' analysis, AtaiBeckley stock appears to be overvalued. The current stock price of $7.18 is trading 7.4% above its estimated GF Value™ of $6.68. GuruFocus considers AtaiBeckley to be Fairly Valued.

Key valuation signals for ATAI:

  • Institutional Ownership: 27.13%
  • GF Value™: $6.68 vs. price of $7.18 (7.4% above fair value)
  • GF Score™: 55/100 with 6 warning signs

No single metric tells the full story. See the ATAI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AtaiBeckley Business Description

Other Exchanges B72:Germany
Address 250 West 34th Street, New York, NY, USA, 10119
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
55GF Score

Get the complete analysis for ATAI

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.18
Price
$6.68
GF Value